Patients diagnosed with glioblastoma survive for an average of 15 months.

What’s needed is a better way of identifying those hidden cancer cells and predicting where the tumor might grow next. Jennifer Munson believes she and her research team at the Fralin Biomedical Research Institute at VTC have developed a tool to do just that.

Their method, described in npj Biomedical Innovations, combines magnetic resonance imaging, Munson’s in-depth knowledge of how fluid moves through human tissues, and an algorithm Munson’s team developed to identify and predict where the cancer might reappear.